INTERLEUKIN-1 Blockade Improves Left Ventricular Performance in Decompensated Heart Failure Without Increasing Myocardial Work (original) (raw)

Interleukin-1 Blockade in Recently Decompensated Systolic Heart Failure

Jessica Regan

Circulation-heart Failure, 2017

View PDFchevron_right

Interleukin-1 Blockade in Recently Decompensated Systolic Heart Failure: Study Design of the Recently Decompensated Heart Failure Anakinra Response Trial (RED-HART)

Juan Raleigh

Journal of Clinical Trials in Cardiology, 2015

View PDFchevron_right

Anti-inflammatory Cytokine Profile in Human Heart Failure

Hitonobu Tomoike

Japanese Circulation Journal, 1999

View PDFchevron_right

The role of cytokines in disease progression in heart failure

Kesavan Shan

Current Opinion in Cardiology, 1997

View PDFchevron_right

Introductory Editorial - Heart Failure: An Exploration of Recent Advances in Research and Treatment (A)

Allison McLarty

Clinical Medicine Insights: Cardiology, 2015

View PDFchevron_right

Rationale and design of interleukin-1 blockade in recently decompensated heart failure (REDHART2): a randomized, double blind, placebo controlled, single center, phase 2 study

Amr Marawan

Journal of Translational Medicine

View PDFchevron_right

Inflammatory markers in stable heart failure and their relationship with functional class

Luis Almenar

International Journal of Cardiology, 2008

View PDFchevron_right

Novelties in the early management of acute heart failure syndromes

F. Sibellas

Swiss Medical Weekly, 2010

View PDFchevron_right

A study of inflammatory markers and their correlation with severity, in patients with chronic heart failure

Owais Mohammad

View PDFchevron_right

Effect of Interleukin-1 Blockade on Left Ventricular Systolic Performance and Work: A Post Hoc Pooled Analysis of 2 Clinical Trials

Jessica Regan

Journal of cardiovascular pharmacology, 2018

View PDFchevron_right

Navigating the Crossroads of Coronary Artery Disease and Heart Failure

Philip Binkley

Circulation, 2006

View PDFchevron_right

Yet Another (Important) Goal for Heart Failure Patients

Marc Silver

JACC. Heart failure, 2018

View PDFchevron_right

Cardiac remodeling as a consequence and cause of progressive heart failure

Dinesh Kalra

Clinical Cardiology, 1998

View PDFchevron_right

Contemporary Drug Development in Heart Failure

Amirul Arif

Lippincott Williams & WilkinsHagerstown, MD, 2015

View PDFchevron_right

Global Research of Chronic Heart Failure

Mousavi Chelak

Journal of Guilan University of Medical Sciences, 2017

View PDFchevron_right

Highlights from the British Society for Heart Failure 20th Annual Autumn Meeting: three decades of heart failure

Alexandra Abel

Future Cardiology, 2018

View PDFchevron_right

Biology of TNFα and IL-10, and their imbalance in heart failure

Jan Slezak

Heart Failure Reviews, 2008

View PDFchevron_right

An Analysis of Epidemiological Factors in Heart Failure Outcomes

sai batchu

Cureus, 2022

View PDFchevron_right

Congestive Heart Failure

Maryl Johnson

1999

View PDFchevron_right

Predicting Short-Term Mortality in Advanced Decompensated Heart Failure

marco matteo Ciccone

Circulation Journal, 2015

View PDFchevron_right

Contemporary Drug Treatment of Advanced Heart Failure with Reduced Ejection Fraction

Julie Kiranjot K Vishram-Nielsen

Drugs, 2022

View PDFchevron_right

Relationships Between Right Ventricular Function, Body Composition, and Prognosis in Advanced Heart Failure

Jan Kovar

Journal of the American College of Cardiology, 2013

View PDFchevron_right

Rethinking Phase II clinical trial design in heart failure

Kory Lavine

Clinical Investigation, 2013

View PDFchevron_right

Initial Management of Patients with Acute Heart Failure

Gregory Fermann

Heart Failure Clinics, 2013

View PDFchevron_right

Biomarkers for Diagnosis and Prognosis of Acute Heart Failure

Salvatore Di Somma

Current Emergency and Hospital Medicine Reports, 2013

View PDFchevron_right

Prognostic Value of Circulating Regulatory T Cells for Worsening Heart Failure in Heart Failure Patients With Reduced Ejection Fraction

Nikolaos Kentepozidis

International Heart Journal, 2014

View PDFchevron_right

One-year follow-up of heart failure patients after their first admission

S. Miravet

QJM, 2004

View PDFchevron_right

Cardiorenal Biomarkers in Acute Heart Failure

bhappil sharma

老年心脏病学杂志：英文版, 2012

View PDFchevron_right

Baseline characteristics of patients with heart failure and preserved ejection fraction included in the Karolinska Rennes (KaRen) study

Inder Anand

Archives of Cardiovascular Diseases, 2014

View PDFchevron_right

The Therapy and Management of Heart Failure with Preserved Ejection Fraction: New Insights on Treatment

Giulio Balestrieri

Cardiac failure review, 2024

View PDFchevron_right

Acute heart failure with and without acute coronary syndrome: clinical correlates and prognostic impact (From the HEARTS registry)

Asif Sheir Malik

BMC Cardiovascular Disorders, 2016

View PDFchevron_right

Cardiac Dysfunction, Congestion and Loop Diuretics: their Relationship to Prognosis in Heart Failure

Parin Shah

Cardiovascular Drugs and Therapy, 2016

View PDFchevron_right

Stable but Progressive Nature of Heart Failure: Considerations for Primary Care Physicians

Inder Anand

American Journal of Cardiovascular Drugs, 2018

View PDFchevron_right

Myocardial Viability and Survival in Ischemic Left Ventricular Dysfunction

imtiaz ali

New England Journal of Medicine, 2011

View PDFchevron_right

Heart Failure with Preserved Ejection Fraction in Older Adults

Caroline Jane Magri

The American Journal of Medicine, 2009

View PDFchevron_right